Variantyx

Biotech & Life Sciences · Herzliya, Israel · Founded 2014

Providing comprehensive genetic testing using a single method approach that is based on whole genome sequencing MoreLess

Variantyx is a technology-driven molecular diagnostics company focused on precision medicine. The company provides advanced genomic testing solutions to aid in the diagnosis of rare genetic disorders, as well as for the reproductive health and precision oncology markets.

Its core business revolves around proprietary whole-genome sequencing and analysis platforms. These platforms are designed to deliver comprehensive genetic insights from a single test, which helps clinicians in diagnosing diseases and formulating personalized treatment plans. The company serves healthcare providers, hospitals, and other clinical settings that require detailed genetic diagnostics.

Variantyx operates in the healthcare and biotechnology sectors, specifically within the molecular diagnostics market. Its business model is based on providing fee-for-service genomic testing. Revenue is generated by billing for the various tests performed, with options for insurance claims and self-pay, targeting a client base that includes patients needing diagnostic services for genetic conditions, prenatal screening, or cancer treatment.

Keywords: molecular diagnostics, genomic testing, precision medicine, rare genetic disorders, reproductive health, oncology, whole-genome sequencing, genetic analysis, personalized treatment, diagnostic solutions

Valuation $100–500M

Headcount 100–500

Total funding $100–500M

Unlock exact values

Company overview

Variantyx company information

The essential company record, classifications and operating signals in one place.

Status: Operational
Founded: 2014
Headquarters: Herzliya, Israel
Employees: 224
Open positions: 10
Dealroom signal: 87.4

Website ↗LinkedIn ↗X ↗

client focusb2bsub industryBioTechnologysectorPersonal Healthbusiness modelManufacturingsectorTestingindustryHealthsectorBiotechnologysectorDNAsectorGenetics and genomicssectorNon-Invasive medical devices and treatmentssectorHealth DiagnosticssectorSpinoutsectorBiotech and Pharmasectormedical testing

Valuation & funding

Variantyx funding history

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VCOther financing	Apr 2024	$36M	$144M	Pitango Venture Capital · Peregrine Ventures · New Era Capital Partners · Bosch Ventures	↗
LATE VCOther financing	Oct 2023	$0	—	Pitango Venture Capital · Bosch Ventures · Peregrine Ventures · 20/20 HealthCare Partners	↗
DEBTDebt	Oct 2022	$20M	—	Kreos Capital	↗
SERIES COther financing	Feb 2022	$42M	$166M	Peregrine Ventures · New Era Capital · Pitango Venture Capital · Bosch Ventures	↗
SERIES COther financing	Nov 2021	$6M	$100M	Bosch Ventures	↗
SERIES COther financing	Mar 2021			20/20 HealthCare Partners · GHS Fund · Pitango Venture Capital · IBM Ventures	—
EARLY VCOther financing	Jun 2019			Pitango Venture Capital	—
SERIES AOther financing	Dec 2017			Undisclosed	—
SEEDOther financing	Jul 2014			Undisclosed	—
SPINOUTOther financing	May 2014			Tel Aviv University	—

Showing 10 recorded eventsUnlock the complete deal history →

Growth signals

Variantyx website traffic

Latest recorded traffic for Variantyx is 11K monthly website visits, up 10% over the last three months. Variantyx's team grew 0.9% over the past year.

Latest monthly visits11K 3-month web change+10% 1-year team growth+0.9%

Monthly website visits103 observations · Oct 2017–Jul 2026

Hover or focus a point to see its exact monthly valueCompare with peers →

Hiring

Open positions at Variantyx

Current openings linked to this company in Dealroom.

Senior Software Engineer, Bioinformatics75 Eliyahu Golomb Street, Herzliya, Tel Aviv District, Israel · Backend Development · Jul 18, 2026 Senior Accountant75 Eliyahu Golomb Street, Herzliya, Tel Aviv District, Israel · Accounting · Jun 30, 2026 Cell Culture TechnologistFramingham, MA · Other · Jun 24, 2026 Accessioner / Lab AssistantFramingham, MA · Other · Jun 15, 2026 Human Resources Business Partner (Temporary)Framingham, MA · Human Resources · Jun 11, 2026

5 distinct openings shownExplore hiring signals →

Comparisons

Variantyx compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
GEGeneticurePharmacogenomic tests to control large, chronic diseases faster than trial/error	Minneapolis, United States	Operational	9	$4.3M	$1M
CACareDxInnovative noninvasive testing solutions enhancing transplant patient outcomes throughout their journey	Brisbane, United States	Operational
IGIgentifyDigital platform for genetic tests providers	Haifa, Israel	Operational
MUMultiplicom#Multiplicom is the leading Belgian biotech company that develops, manufactures and commercializes molecular diagnostic tests that enable personalized medicine	Antwerp, Belgium	Acquired
SGSinglera GenomicsA developer of 'liquid biopsy' analysis reagents and software, focusing on determing methylation haplotypes across many thousands of genomic locations in cell-free DNA	San Diego, United States	Operational
INInflammatixDeveloping novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system	Sunnyvale, United States	Operational
MLMedGenome LabsA genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome	Foster City, United States	Operational
GEGenapsysA company focused on the advancement of universal access to genomic information by delivering an affordable, scalable, and accurate genomic sequencing ecosystem that empowers both academic and clinical research applications	Redwood City, United States	Operational

Showing 8 of the closest matchesCompare every metric →

Talent graph

Variantyx's talent

Book a demo to see the people

Team profiled 13 named & role-tagged

Founders /100 quality score

Key operators 4 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

10 investors on Variantyx's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Pitango Venture Capital

Series B+ 8 investors entered at this stage

20/20 HealthCare Partners

GHS Fund

IBM Ventures

New Era Capital Partners

Bosch Ventures

New Era Capital

Peregrine Ventures

Kreos Capital

Other known 1 additional known investor

Tel Aviv University

Global footprint

Where Variantyx has talent and traffic

Workforce by country

3 countries with
team presence

🇺🇸 United States80%

🇮🇱 Israel19.4%

🇩🇪 Germany0.6%

3 countries shown

In the news

Latest news about Variantyx

Recent press, funding announcements, and product moves mentioning Variantyx — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Variantyx

An AI-synthesized read of the highest-engagement posts about Variantyx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Variantyx’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.